Collection
The COVID-19 Antivirals and Therapeutics Taskforce
The DHSC-led COVID-19 Antivirals and Therapeutics Taskforce co-ordinates the end-to-end provision of treatments for coronavirus (COVID-19) in the UK so patients get access to safe and effective treatments as soon as possible.
The COVID-19 Antivirals and Therapeutics Taskforce
The COVID-19 Antivirals and Therapeutics Taskforce is responsible for the end-to-end provision of treatments for coronavirus (COVID-19) in the UK.
The taskforce is responsible for:
- identifying potential COVID-19 therapeutics
- trialling these as part of an advanced programme of clinical trials
- deploying effective treatments to UK patients
The taskforce works with industry experts to identify, develop and procure novel oral antivirals (those in pill or tablet form) that patients can take promptly following infection.
Contact details
Email: attf@dhsc.gov.uk
For Freedom of Information requests, please contact DHSC.
Further information
Access to community treatments
Clinical trials
Published 6 September 2022